EDGAR·FLOW

vTv Therapeutics Inc. — Form SCHEDULE 13D/A

Filed November 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A — Neutral significance 28/100
What the filing says
Samsara BioCapital, L.P. filed an amended Schedule 13D/A regarding its beneficial ownership position in vTv Therapeutics Inc. (market cap ~$22.4M). The filing document does not disclose specific share counts, ownership percentages, dollar amounts of the amended position, or the nature of changes from the original filing. Without access to the actual amendment details, the materiality of this disclosure change cannot be assessed.
Why this rating

Schedule 13D/A amendments are routine SEC filings. Without disclosed specifics (shares, %, amounts), appears administrative. Significance depends entirely on undisclosed amendment substance.

View original filing on SEC.gov ↗ VTVT · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.